SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-26
👔
Niagen Bioscience, Inc.
@NAGE_InsiderForm 4 Filing: Shahbazi Hamed Acquires (Grant) shares of $NAGE
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Niagen Bioscience, Inc.
Ticker: $NAGE
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-24
Shares: 31,746
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Shahbazi Hamed, holds the title of Director at Niagen Bioscience, Inc..
On 2026-06-24, the insider transacted 31,746 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Shahbazi Hamed (Director) was granted $0 of $NAGE
Post-Transaction Position: 31,746 shares
SEC Accession No: 0001942711-26-000001 (CIK: 1942711)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.